Beximco Pharmaceuticals Ltd.
New product launched in 2020
Beximco Pharmaceuticals Ltd. (BPL), a leading pharmaceutical in Bangladesh having global footprint across 55 countries with its prescription medicine and bringing new technology and generic. BPL launched 30 products in 2020 across Analgesic, Cardiovascular, Endocrine Disorders, Antibiotics, Anti-viral, Respiratory and Urogenital portfolios. On May 21, 2020 Beximco Pharma became the first in the world to launch generic Remdesivir (under the brand name Bemsivir®). Beximco Pharma has also supplied Remdesivir to a number of countries on humanitarian ground.
Napa One® Tablet
Napa One® is a fast acting and safe analgesic with marked antipyretic property. It is especially suitable for patients who, for any reason, cannot tolerate aspirin or other analgesics.
Napa® One is indicated for all conditions requiring relief from pain and fever such as neuritis, neuralgia, headache, earache, toothache, pain due to rheumatic disorder, cold, influenza & dysmenorrhoea.
Bemsivir® IV Injection (First time in Bangladesh)
Bemsivir® is an investigational nucleotide analog with broad-spectrum antiviral activity.
Bemsivir® is authorized for use under an Emergency Use Authorization (EUA) for treatment of patients hospitalized with suspected or laboratory confirmed SARS-CoV-2 infection and severe disease.
Ivermectin 6mg & 12mg tablet
Ivera® is an antiparasitic medicine used to treat the following infection:
- Treatment of intestinal strongyloidiasis.
- Treatment of parasites in the blood or tissue caused by Wuchereria bancrofti.
- Treatment of human scabies after prior treatment has failed.
- In clinical trials at ICDDR,B, Bangladesh, Ivermectin shows promises against COVID-19.
Moxifloxacin 400 mg
Odycin Tablet is a fluoroquinolone antibacterial indicated for treating infections in adults (18 years of age and older) caused by designated susceptible bacteria.
Viraflu® Tablet (First time in Bangladesh)
Favipiravir 200 mg tablet
Viraflu® is a modified pyrazine analog that was initially approved for therapeutic use in resistant cases of influenza. It should be considered for use only when there is an outbreak of novel or re-emerging influenza virus infections.
Amdopril® 5/5 Tablet
Perindopril arginine+Amlodipine 5mg/5mg
Amdopril® works by widening and relaxing the blood vessels so that blood passes through them more easily and makes it easier for the heart to maintain a good blood flow. Amdopril® 5/5 Tablet is indicated for treatment of hypertension and/or stable coronary artery disease, in patients already controlled with Perindopril Arginine and/or Amlodipine given concurrently at the same dose level.
Rivaroxaban 2.5mg, 10mg , 15mg & 20mg
Kinexa® is an anticoagulant and the first orally active direct factor Xa inhibitor. Kinexa is indicated for the prevention of venous thromboembolic events (VTE) in patients who have undergone total hips and knee replacement surgery; prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE); to reduce risk of recurrent DVT and/or PE.
Endocrine & Diabetes
Glipita® M XR 1000 Tab
Glipita® M XR tablets contain two oral antihyperglycemic drugs used in the management of type 2 diabetes: Sitagliptin and Metformin Hydrochloride.
Jardimet® 5/500 Tablet (First time in Bangladesh)
Empagliflozin/Metformin Hydrochloride 5mg/500mg
Jardimet® is a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Acifix® 20 mg capsule (Vegecap)
Rabeprazole 20 mg
Acifix® is prescription medicine in the class of proton pump inhibitors. It is indicated for faster relief from Acid Peptic Diseases. It works by reducing the amount of acid in stomach by inhibiting proton pump. It provides faster onset of action due to higher Pka value of Rabeprazole Sodium.
REMMO® MUPS (Multiple Unit Pellet System)
Esomeprazole 20 mg, Esomeprazole 40 mg
REMMO®, a Buffered Esomeprazole MUPS (Multiple-Unit Pellet System) formulation, has come up with distinct tangible benefits to solve the core defects behind existing PPIs’ treatment failure.
REMMO® is different-
- We are using 99.9% purest form of Esomeprazole in REMMO®. Thus, REMMO® ensures superb efficacy.
- Each REMMO® pearlescent tablet contains 710-720 Esomeprazole MUPS pellets along with a granulated buffering agent, ensuring approx. 97% gastro-protection of Esomeprazole MUPS.
- REMMO® pearlescent tablets use the smallest and most concentrated Esomeprazole MUPS pellets of 22.5% USP grade ranging from 250 microns in size. These micro-pellets act as “fluid” and reach into the absorption site of the intestine without interacting stomach’s food contents.
- REMMO® is a “BUFFERED” formulation and acts through dual-mode of action – after taking the tablet, the buffering component is released and reacts with stomach acid & neutralizes within 5 minutes that lasts up to 30 minutes. Moreover, the buffering agent increases the pH level of the stomach to protect Esomeprazole MUPS from highly acidic gastric juice.
Rostil® Plus Sachet
Esomeprazole 20 mg, Esomeprazole 40 mg
Rostil® Plus Sachet provides effective relief from the painful spasms and cramps and at the same time will help to restore and maintain bowel regularity. For the treatment of Irritable Bowel Syndrome (IBS) associated with Constipation and in the treatment of patients requiring a high fiber regime: for example, for the relief of constipation.
Hydroxychloroquine Sulphate 200mg
Kovicin® is synthetically produced version of quinine indicated in
- Acute and chronic rheumatoid arthritis
- Systemic Lupus Erythematosus (SLE)
Topita® SR Tablet
Tapentadol INN 50 mg sustained release tablet, Tapentadol INN 100 mg sustained release tablet
Topita® SR Tablet is a centrally-acting synthetic analgesic. Topita® SR Tablet causes large increases in levels of extracellular norepinephrine (NE) due to a dual mechanism of action involving mu opioid receptor (MOR) agonism as well as noradrenaline reuptake inhibition. Topita® SR Tablet is indicated for the relief of moderate to severe acute pain in patients 18 years of age or older.
Ogivri® Lyophilized Powder for Injection
Ogivri® USFDA & EMA approved first biosimilar Trastuzumab which is a humanised IgG1 monoclonal antibody. Ogivri® is indicated in Metastatic Breast Cancer, Early Breast Cancer and Metastatic Gastric Cancer. Ogivri® is the product of Mylan Pharmaceuticals Inc., world’s second largest generic company, Headquarter in Pennsylvania, USA.
Dynase® Nasal Spray
Azelastine Hydrochloride + Fluticasone propionate (137mcg+50mcg)/spray
Dynase® targets six allergic substances for inflammatory response, i.e histamine, platelet activating factor, interleukins, prostaglandins, triptase and leukotriene and give complete relief from allergic symptoms.
Dynase® is used to relieve seasonal allergy symptoms of the nose such as sneezing, runny nose, itchy nose, blocked nose, sinus pain and congestion and watery eye with redness
Symbion® Maxhaler® (First time in Bangladesh)
Budesonide/Formoterol Fumarate Dihydrate 100mcg/6mcg per actuation
Budesonide/Formoterol Fumarate Dihydrate 200mcg/6mcg per actuation
Budesonide/Formoterol Fumarate Dihydrate 400mcg/12mcg per actuation
Symbion® F Maxhaler® is a Multi dose Dry Powder Inhaler, combination of Formoterol Fumarate Dihydrate BP and Budesonide BP. Formoterol Fumarate is a selective, long acting β2 agonist used in the treatment of asthma and other forms of diffuse airways obstruction. Budesonide is a corticosteroid with mainly glucocorticoid activity. Budesonide is stated to exert a topical effect on the lungs without systemic effects at usual dose.
Maxhaler® is a moulded plastic device containing a foil strip with 60 regularly placed blisters containing pre-dispensed inhalation powder. Symbion® is indicated in the regular treatment of asthma and COPD.
Glycopyrronium Dry Powder Inhaler Capsule
Glyriva® Bexicap® capsule contains Glycopyrronium as the active ingredient which is a long-acting muscarinic antagonist, which is often referred to as an anticholinergic. Glyriva® Bexicap® is indicated as a maintenance bronchodialator treatment to relieve symptoms of adult patients with chronic obstructive pulmonary disease (COPD). Glyriva® Bexicap® is not indicated for the initial treatment of acute episodes of bronchospasm, i.e. as a rescue therapy.
Mirasol® XR Tablet
Mirabegron 25 mg & 50mg
Mirasol® XR is a beta 3 adrenergic agonist approved by the FDA to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage in adults. Mirasol® is the first and only drug in its class for OAB. Mirasol® XR is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and urinary frequency.
Vitamins & Minerals Supplement
Becoral® D Tablet
Coral Calcium 500mg and Vitamin D3 200IU
Becoral® D is a combined preparation of Coral Calcium and Vitamin D (Cholecalciferol) specially designed to strengthen bone.
Becoral® D is used to prevent or treat low blood calcium levels in people who do not get enough calcium from their diets. It may be used to treat conditions caused by low calcium levels such as bone loss (osteoporosis), weak bones (osteomalacia/rickets), decreased activity of the parathyroid gland (hypoparathyroidism)
Becoral® DX Tablet
Coral Calcium 600mg and Vitamin D3 400IU
Becoral® DX is a combined preparation of Coral Calcium and Vitamin D (Cholecalciferol) specially designed to strengthen bone.
Becoral® DX is used to prevent or treat low blood calcium levels in people who do not get enough calcium from their diets. It may be used to treat conditions caused by low calcium levels such as bone loss (osteoporosis), weak bones (osteomalacia/rickets), decreased activity of the parathyroid gland (hypoparathyroidism)